Abstract

BackgroundIt is well established that many gastroesophageal (GE) cancers are immune-sensitive. Programmed death ligand-1 (PD-L1) expression may have a predictive value in GE cancers. PD-L1/PD-1 inhibitors have profoundly influenced the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call